Medication info

Albidus Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201902581 · Approved 2019.04.24

This product's status changed to Expired on 2024.04.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of ulcers (gastric, duodenal, etc.) and acid-related disorders (gastritis, etc.); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
Usually administer 2 tablets per dose orally twice daily, regardless of meals, in the morning and before bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily or 4 tablets once daily before bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and before bedtime. The same dose applies to ulcers caused by nonsteroidal anti-inflammatory drugs and to combination therapy for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use generally heal within 4 weeks, and ulcers generally heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily before bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets per dose 3 times daily and increase the dose if needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets per dose on the night before surgery.

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of ulcers (gastric, duodenal, etc.) and acid-related disorders (gastritis, etc.); prevention of Mendelson syndrome

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric ulcers caused by NSAIDs
  • duodenal ulcers caused by NSAIDs
View approved original text

This medication is used for diseases such as gastric and duodenal ulcers, gastritis, and Zollinger-Ellison syndrome. It is also helpful in the treatment of gastroesophageal reflux disease and is administered to prevent Mendelson's syndrome prior to surgery. It is utilized for the treatment of gastric and duodenal ulcers caused by the use of nonsteroidal anti-inflammatory drugs (NSAIDs). It is effective in alleviating and treating the symptoms of various gastrointestinal-related diseases.

How to take

Adult dose

Usually administer 2 tablets per dose orally twice daily, regardless of meals, in the morning and before bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily or 4 tablets once daily before bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and before bedtime. The same dose applies to ulcers caused by nonsteroidal anti-inflammatory drugs and to combination therapy for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use generally heal within 4 weeks, and ulcers generally heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily before bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets per dose 3 times daily and increase the dose if needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets per dose on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those with reduced kidney function. It should also not be given to individuals who are allergic to this drug or its components, those with a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or women who may become pregnant, premature infants and newborns, and those on a dietary regimen restricting potassium intake. Caution is advised in individuals with liver dysfunction, a history of drug allergies, elderly patients, those with a previous history of kidney problems, and patients taking NSAIDs. Especially since it can mask symptoms of gastric cancer, patients with gastric ulcers or middle-aged and older individuals who newly experience dyspeptic symptoms should confirm malignancy before use. Patients with Helicobacter pylori infection associated with gastric or duodenal ulcers require eradication therapy. Critical patients in intensive care or those with hypophosphatemia should also be cautious. This medication can rarely cause severe allergic reactions such as anaphylactic shock; if any unusual symptoms occur during administration, discontinue the medication immediately and seek appropriate treatment. Hypersensitivity reactions such as skin rash, urticaria, angioedema, fever, bronchospasm, and hypotension may also occur, and usage should be stopped if these symptoms appear. Various side effects have been reported, including reduced blood cell counts, liver function abnormalities, arrhythmias, gastrointestinal symptoms, dizziness, drowsiness, and mental confusion, so inform medical personnel if symptoms occur. This medication should not be used for prolonged periods without effect, and other medications should be considered. Regular blood tests and liver and kidney function tests should be performed. Elderly patients or those with chronic conditions may have an increased risk of pneumonia. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so inform medical personnel of any medications being taken, especially when used with certain antibiotics or anticoagulants. Pregnant or breastfeeding women should not use this medication, and safety in children has not been established, so administration is not recommended. Because it can affect test results, caution is needed during urine protein tests, and appropriate emergency measures such as vomiting or gastric lavage may be necessary in case of overdose. Lastly, this medication can reduce gastric acid secretion, promoting bacterial growth in the stomach, and long-term use may lead to side effects related to ocular melanin, necessitating ophthalmic examination.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 50 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • dyskeratosis congenita
  • acquired immune hemolytic anemia
  • eosinophilia
  • generalized malaise
  • weakness
  • subcutaneous and mucosal hemorrhage
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • sense of illness
  • anxiety
  • mental disorientation
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • asthenic muscle cramps
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • reduced libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • mild erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air from entering, and it is best stored at room temperature between 1 degree and 30 degrees Celsius. This will maintain the effectiveness of the medication and ensure safe usage.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.